Published in Histol Histopathol on August 01, 2007
The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci (2009) 3.80
Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci (2009) 2.35
Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies. Epilepsia (2009) 1.98
Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab (2010) 1.35
EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance. Curr Mol Pharmacol (2010) 1.29
Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res (2008) 1.16
The differential diagnosis of familial lentiginosis syndromes. Fam Cancer (2011) 1.12
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett (2011) 1.12
Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets (2010) 1.07
Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene (2010) 1.05
Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword? Cell Cycle (2010) 1.04
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2010) 1.01
Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2009) 0.99
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics (2014) 0.93
Specific roles of Akt iso forms in apoptosis and axon growth regulation in neurons. PLoS One (2012) 0.91
Pediatric low-grade gliomas and the need for new options for therapy: Why and how? Cancer Biol Ther (2009) 0.88
Axonal plasticity of age-defined dentate granule cells in a rat model of mesial temporal lobe epilepsy. Neurobiol Dis (2015) 0.87
Sleep, plasticity and the pathophysiology of neurodevelopmental disorders: the potential roles of protein synthesis and other cellular processes. Brain Sci (2014) 0.83
Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function. Front Cell Neurosci (2016) 0.82
Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells. Cell Signal (2010) 0.80
Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway. Mol Cell Pharmacol (2009) 0.80
Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma. J Child Neurol (2008) 0.79
Lhermitte-Duclos and Cowden diseases: breast cancer as an unusual initial presentation of these overlapping conditions. BMJ Case Rep (2011) 0.77
Stronger is not always better: could a bodybuilding dietary supplement lead to ALS? Exp Neurol (2010) 0.76
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model. Neurol Sci (2014) 0.76
Long-Term Alcohol-Induced Activation of Mammalian Target of Rapamycin is a Key Risk Factor of Epilepsy. Med Sci Monit (2016) 0.75
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas. Cancer (2017) 0.75
The distinct signaling regulatory roles in the cortical atrophy and cerebellar apoptosis of newborn Nbn-deficient mice. Cell Mol Neurobiol (2013) 0.75
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev (1999) 6.87
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A (1998) 5.74
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42
The ARF/p53 pathway. Curr Opin Genet Dev (2000) 4.13
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65
Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J (2005) 2.42
Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol (1997) 2.28
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res (2001) 2.13
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology (2009) 2.00
Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology (2002) 1.90
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene (2008) 1.84
Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet (2000) 1.76
Schmallenberg virus: a seroprevalence survey in cattle and sheep, France, winter 2011-2012. Vet Rec (2013) 1.65
Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene (1997) 1.55
Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology (2001) 1.54
A radioimmunoassay for serum ferritin. Clin Chem (1977) 1.48
In case of difficult intubation with the Airtraq(®): the gum elastic bougie may assist. Ann Fr Anesth Reanim (2011) 1.46
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45
Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem (1999) 1.43
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet (1999) 1.29
Analysis of sigma(54)-dependent genes in Enterococcus faecalis: a mannose PTS permease (EII(Man)) is involved in sensitivity to a bacteriocin, mesentericin Y105. Microbiology (2001) 1.29
Defining the molecular basis of Arf and Hdm2 interactions. J Mol Biol (2001) 1.29
Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet (2000) 1.27
The extended genetic diversity of BVDV-1: typing of BVDV isolates from France. Vet Res Commun (2007) 1.21
Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res (1998) 1.21
Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol (2001) 1.21
Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J Biol Chem (2000) 1.20
Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17
Thermogenesis and weight loss in obese individuals: a primary association with organochlorine pollution. Int J Obes Relat Metab Disord (2004) 1.17
NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol (2001) 1.16
Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol (2000) 1.16
Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol (1988) 1.14
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol (2000) 1.14
Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma. Neurology (2006) 1.09
Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet (2000) 1.09
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08
Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene (2011) 1.05
Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene (2010) 1.05
Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis (1995) 1.02
Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia (2001) 0.99
Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet (1993) 0.99
Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med (2001) 0.97
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. J Pathol (2009) 0.97
Expression of alpha v and beta 3 integrin chains on murine lymphocytes. Proc Natl Acad Sci U S A (1996) 0.97
Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma. Neuroscience (2010) 0.96
Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation. Oncogene (2009) 0.95
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene (2012) 0.95
The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology (2006) 0.95
Ezrin, radixin, and moesin are components of Schwann cell microvilli. J Neurosci Res (2001) 0.94
Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res (1997) 0.94
Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J Neurosci Res (1996) 0.94
Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene (2006) 0.93
Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett (1996) 0.93
The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ (1995) 0.92
Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. Vet Pathol (2009) 0.92
Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am J Physiol (1997) 0.91
Coarctation of the aorta in infancy. Postoperative follow-up. J Thorac Cardiovasc Surg (1969) 0.91
Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein. Biochemistry (2001) 0.90
A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces. J Appl Microbiol (2000) 0.90
[An unusual case of hydatid cyst]. Can J Surg (1976) 0.90
Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1. Eye (Lond) (2011) 0.89
The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum Mol Genet (2000) 0.88
Merlin: hanging tumor suppression on the Rac. Trends Cell Biol (2001) 0.87
Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer. Oncogene (2010) 0.87
Molecular analysis of malignant triton tumors. Hum Pathol (1999) 0.87
Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP. Oncogene (1994) 0.87
Establishment of primary vestibular schwannoma cultures from neurofibromatosis type-2 patients. Int J Oncol (1999) 0.86
Neurofibromatosis type 1: piecing the puzzle together. Can J Neurol Sci (1998) 0.85
The ecology of brain tumors: lessons learned from neurofibromatosis-1. Oncogene (2010) 0.85
Ablation of Go alpha-subunit results in a transformed phenotype and constitutively active phosphatidylcholine-specific phospholipase C. J Biol Chem (1997) 0.84
Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor. Neurology (2006) 0.83
Therapy of symptomatic pyelonephritis in women. J Urol (1985) 0.83
Overexpression of bax in human glioma cell lines. J Neurosurg (1999) 0.83
Characterization and expression of H-21 region gene products on bone marrow-derived macrophages. Eur J Immunol (1982) 0.83
A simple classification of the risk in cardiac surgery. Can Anaesth Soc J (1983) 0.82
Six methodological steps to build medical data warehouses for research. Int J Med Inform (2006) 0.82
[Sudden death and "inverted Tako-Tsubo": think of the brain !]. Ann Fr Anesth Reanim (2012) 0.82
Expression of the neurofibromatosis 1 (NF1) gene during growth arrest. Neuroreport (1996) 0.82
Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues. Neurobiol Dis (1996) 0.81
Postinfarction ventricular septal defect: delayed closure with prolonged mechanical circulatory support. Ann Thorac Surg (1983) 0.81
Oculodentodigital dysplasia with cerebral white matter abnormalities in a two-generation family. Am J Med Genet (1995) 0.81
Genome-wide polymorphism analysis demonstrates a monoclonal origin of pilocytic astrocytoma. Neuropathol Appl Neurobiol (2011) 0.81
Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Ann Neurol (1997) 0.81
Clinical and hemodynamic results with the Carpentier-Edwards porcine bioprosthesis. Ann Thorac Surg (1982) 0.81
Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res (1996) 0.80
Expression of the neurofibromatosis 1 (NF1) gene in reactive astrocytes in vitro. Neuroreport (1995) 0.80
Advances in neurofibromatosis 2 (NF2): a workshop report. J Neurogenet (2000) 0.80
Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. Am J Pathol (1996) 0.80
Twelve-year experience with Carpentier-Edwards PERIMOUNT pericardial valve in the mitral position: a multicenter study. J Heart Valve Dis (1998) 0.80
Integrated MR imaging and proton nuclear magnetic resonance spectroscopy in a family with an X-linked spastic paraparesis. AJNR Am J Neuroradiol (1991) 0.80
Juvenile xanthogranuloma, neurofibromatosis 1, and juvenile chronic myeloid leukemia. Arch Dermatol (1996) 0.79
Resolution of optical isomers by high-pressure liquid chromatography. The separation of benzo[a]pyrene trans-diol derivatives. Anal Biochem (1977) 0.79
An alternative apnea test for the evaluation of brain death. Ann Neurol (1991) 0.79
Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration. Dev Dyn (2004) 0.79
The question of familial meningiomas and schwannomas: NF2B or not to be? Neurology (2000) 0.79
Neurofibromatosis 2 and malignant mesothelioma. Neurology (2002) 0.79
Major histocompatibility complex regulation of the immune response. J Surg Res (1985) 0.79